z-logo
Premium
P3‐283: Randomized double‐blind placebo‐controlled dose‐finding trial of intravenous immunoglobulin (octagam® 10%, octapharma AG) in patients with Alzheimer's disease
Author(s) -
Farlow Martin R.,
Jessen Frank,
Wietek Stefan,
Melsen Tina,
Haag Stefan,
Dodel Richard
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.1783
Subject(s) - medicine , placebo , randomized controlled trial , clinical trial , adverse effect , autoantibody , antibody , immunology , pathology , alternative medicine

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here